In line with this, specific deletion of glucose transporter 1 (GLUT1) in tumor‐infiltrating macrophages or inhibition of glycolysis by 2‐deoxyglycose (2‐DG) reversed their protumoral profile and decreased PDAC tumor burden [65]. Here, SLC2A1 is linked to neoplasm.